Nora Choque OlssonAssociate Professor, Lic. Psychologist, Lic. Psychotherapist, Specialist in Clinical Psychology
About me
I am medicine doctor in Psychology, licensed psychologist, licensed psychotherapist (CBT),and specialist in clinical psychology. I have about 20 years of clinical experience working with diagnosis, treatment and supervision in psychiatry. A large part of my involvement in healthcare has been the coordination and leadership of several different projects, including the development and writing of guidelines for assessment and treatment for children and young people with autism and ADHD and the development of a specialist training for psychologists in clinical child and adolescent psychology. Furthermore, I have several years of experience teaching in advanced training programs.
Teaching
The areas I teach are cognitive-behavioral therapy (CBT), basic skills in CBT, assessment, investigation and interventions for children and adolescents, ethics and theory of science and research methodology. I am responsible for the following courses: CBT in theory and application (10hp), Assessment and interventions for the individual, children and adolescents (7,5 hp), Ethics for Psychotherapists and Psychological Specialists (2,5 hp), Theory of Science and Research Methodology in Psychotherapy I (4hp) and II (3,5 hp). I also give lectures on various courses and programs on different aspects of assessment, investigation and interventions for children, adolescents and adults with autism and ADHD. Furthermore, I supervise students who work with theses in the psychology program and the psychotherapist program.
Research
I am interested in research on psychotherapy research (CBT), neuropsychology and instrument validation. I am particularly interested in underlying mechanisms of treatment outcome, interventions for people with disabilities, social cognition, emotion regulation and communication. In 2016, I received my PhD from the Department of Women's Health, Karolinska Institutet with the thesis Social skills training in groups for children and adolescents with autism.
I work with both quantitative and qualitative research methods as well as with systematic reviews and meta-analyses. The results of my studies have been presented at both national and international conferences, in the form of chapters in clinical manuals, and in journals and seminars. See the ongoing research projects here.
Research projects
Publications
A selection from Stockholm University publication database
-
Rare variants in the outcome of social skills group training for autism
2021. Danyang Li (et al.). Autism Research
ArticleExome sequencing has been proposed as the first-tier genetic testing in autism spectrum disorder (ASD). Here, we performed exome sequencing in autistic individuals with average to high intellectual abilities (N = 207) to identify molecular diagnoses and genetic modifiers of intervention outcomes of social skills group training (SSGT) or standard care. We prioritized variants of clinical significance (VCS), variants of uncertain significance (VUS) and generated a pilot scheme to calculate genetic scores of rare and common variants in ASD-related gene pathways. Mixed linear models were used to test the association between the carrier status of VCS/VUS or the genetic scores with intervention outcomes measured by the social responsiveness scale. Additionally, we combined behavioral and genetic features using a machine learning (ML) model to predict the individual response. We showed a rate of 4.4% and 11.3% of VCS and VUS in the cohort, respectively. Individuals with VCS or VUS had improved significantly less after standard care than non-carriers at post-intervention (β = 9.35; p = 0.036), while no such association was observed for SSGT (β = −2.50; p = 0.65). Higher rare variant genetic scores for synaptic transmission and regulation of transcription from RNA polymerase II were separately associated with less beneficial (β = 8.30, p = 0.0044) or more beneficial (β = −6.79, p = 0.014) effects after SSGT compared with standard care at follow-up, respectively. Our ML model showed the importance of rare variants for outcome prediction. Further studies are needed to understand genetic predisposition to intervention outcomes in ASD.
-
Treatment satisfaction with cognitive-behavioral therapy among children and adolescents with anxiety and depression
2021. Nora Choque Olsson (et al.). Journal of Behavioral and Cognitive Therapy 31 (2), 147-191
ArticleRecent reviews estimated that the worldwide prevalence of anxiety and depression in children and adolescents is increasing, which has led to rising demands for treatment. Studies on clinical outcomes have shown positive effects of cognitive-behavioral therapy (CBT) in children and adolescents with anxiety and depression. However, there is a limited body of studies on the perspectives and experiences of the treatment participants. The objective of this review was to investigate treatment satisfaction with CBT among children and adolescents with anxiety and depression. We focused on the reporting quality of the treatment satisfaction and experiences of participants in the selected studies. From 1379 identified studies, 35 were selected based on inclusion and exclusion criteria. The results of a meta-synthesis and proportional meta-analysis suggest moderate to high treatment satisfaction with CBT in depressed and anxious children and adolescents. The included studies showed moderate to good reporting quality on treatment satisfaction. The measurements used varied, indicating a risk of different evaluations under the concept of “treatment satisfaction”. The common topics measured for treatment satisfaction were acceptability, treatment usefulness, alliance, barriers, recommendation, and others, leading to uncertainty concerning generalization. A wide variety of measures were used, indicating the need for standardized measures for treatment satisfaction in future research.
Show all publications by Nora Choque Olsson at Stockholm University
$presentationText